Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1R
| Autor: | Timothy P. Heffernan, Angela L. Harris, Martin R. Tremblay, Connor A. Parker, Yongying Jiang, Robert A. Mullinax, Cross Jason, Jihai Pang, Qi Wu, Edward Q. Chang, Sonal Gera, Keith M. Wilcoxen, Paul G. Leonard, Zhen Liu, Jeffrey J. Kovacs, Erika Suzuki, Barbara Czako, Ningping Feng, Joseph R. Marszalek, Nakia D. Spencer, Pijus K. Mandal, Jason P Burke, Simon S. Yu, Keith Mikule, Faika Mseeh, Philip Jones, Giulio Draetta |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Molecular Structure
THP-1 Cells Chemistry Macrophage polarization Antineoplastic Agents Phenotype Structure-Activity Relationship Pyrimidines Drug Stability Receptors Granulocyte-Macrophage Colony-Stimulating Factor Neoplasms Tumor-Associated Macrophages Drug Discovery Microsomes Liver Cancer research Humans Molecular Medicine Structure–activity relationship THP1 cell line Benzothiazoles Kinase activity Signal transduction Receptor Function (biology) |
| Zdroj: | Journal of Medicinal Chemistry. 63:9888-9911 |
| ISSN: | 1520-4804 0022-2623 |
| Popis: | Tumor-associated macrophages (TAMs) have a significant presence in the tumor stroma across multiple human malignancies and are believed to be beneficial to tumor growth. Targeting CSF1R has been proposed as a potential therapy to reduce TAMs, especially the protumor, immune-suppressive M2 TAMs. Additionally, the high expression of CSF1R on tumor cells has been associated with poor survival in certain cancers, suggesting tumor dependency and therefore a potential therapeutic target. The CSF1-CSF1R signaling pathway modulates the production, differentiation, and function of TAMs; however, the discovery of selective CSF1R inhibitors devoid of type III kinase activity has proven to be challenging. We discovered a potent, highly selective, and orally bioavailable CSF1R inhibitor, IACS-9439 (1). Treatment with 1 led to a dose-dependent reduction in macrophages, promoted macrophage polarization toward the M1 phenotype, and led to tumor growth inhibition in MC38 and PANC02 syngeneic tumor models. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|